EUVIMEDEUVIMED entdecken
Crossref

GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration

LanLan Gan, Lu Zhou, ALan Chu, Chen Sun, YongTai Wang, MengLin Yang, ZongWen Liu

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-10070-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von LanLan Gan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Radiotherapy Department, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, P.R. China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Signal Transduction, Esophageal Squamous Cell Carcinoma, Computational Biology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Esophageal squamous carcinoma (ESCC) is the most prevalent pathological subtype of esophageal cancer (EC). It has the characteristics of significant local invasion, quick disease progression, high recurrence rates, and a dismal prognosis for survival. Phosphatidylinositol 3-kinase/serine-threonine kinase (PI3K/AKT) is a signaling system whose aberrant activation regulates downstream factors, leading to the promotion of cancer development. This study looks at a protein called Glycerol-3-phosphate dehydrogenase 1-like (GPD1L), which strongly affects the development of several cancers. However, its association with ESCC development and its underlying mechanisms are not clear. METHODS: In this paper, we analyzed six ESCC transcriptome data obtained from the GEO database. We utilized bioinformatics technology and immunohistochemistry to differentially analyze GPD1L levels of mRNA and protein expression in ESCC and normal adjacent tissues. Furthermore, we conducted survival, co-expression, enrichment, immune infiltration and drug sensitivity analysis. Moreover, we further investigated the role and mechanism of GPD1L by Western Blot (WB), Cell Counting Kit-8 (CCK8), wound healing assay, Transwell assay, and flow cytometry. Finally, the addition of IGF-1, the activator of PI3K/AKT, could rescue the inhibitory effect of GPD1L on ESCC. RESULTS: The findings manifest that the expression of GPD1L was low in ESCC, and functional experiments showed that GPD1L promoted apoptosis in vitro while blocking cell migration, invasion, and proliferation. Based on mechanism research, GPD1L's impact on ESCC could be explained by its suppression of the PI3K/AKT signaling pathway's activation. CONCLUSION: To sum up, our findings imply that GPD1L may impede the initiation and advancement of ESCC via modulating the PI3K/AKT signaling pathway. GPD1L is considered to be a promising therapeutic target and biomarker to diagnose and treat ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktSignal TransductionEsophageal Squamous Cell CarcinomaComputational BiologyEsophageal NeoplasmsGene Expression Regulation, NeoplasticPhosphatidylinositol 3-KinasesHumansCell Line, TumorCell ProliferationGlycerolphosphate DehydrogenaseCell MovementPrognosisApoptosis

Stichwörter der Autor:innen

BioinformaticsBiological behaviorESCCGPD1LPI3K/AKT

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesGlycerolphosphate Dehydrogenase

Autor:innen und Institutionen

  • Tumor Radiotherapy Department, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, P.R. China.
  • Tumor Radiotherapy Department, The Second Clinical Medical School of Zhengzhou University, Zhengzhou, Henan, 450000, P.R. China.
  • Tumor Radiotherapy Department, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, P.R. China. liuzwhh@sina.com.

Zitieren

APA

Gan, L., Zhou, L., Chu, A., Sun, C., Wang, Y., Yang, M., & Liu, Z. (2024). GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-10070-1

Vancouver

Gan L, Zhou L, Chu A, Sun C, Wang Y, Yang M, et al. GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-10070-1

BibTeX
@article{Gan2024,
  author = {Gan, LanLan and Zhou, Lu and Chu, ALan and Sun, Chen and Wang, YongTai and Yang, MengLin and Liu, ZongWen},
  title = {GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-10070-1}
}
Kostenlos starten →